Federated Hermes’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,489
Closed -$243K 2055
2024
Q4
$243K Sell
25,489
-5,463
-18% -$55.3K ﹤0.01% 1456
2024
Q3
$348K Buy
30,952
+51
+0.2% +$542 ﹤0.01% 1399
2024
Q2
$309K Buy
30,901
+101
+0.3% +$1.03K ﹤0.01% 1408
2024
Q1
$355K Sell
30,800
-674,325
-96% -$5.73M ﹤0.01% 1400
2023
Q4
$5.14M Buy
705,125
+613,882
+673% +$4.84M 0.01% 711
2023
Q3
$830K Sell
91,243
-29,343
-24% -$352K ﹤0.01% 1184
2023
Q2
$1.47M Sell
120,586
-53,099
-31% -$592K ﹤0.01% 1049
2023
Q1
$2.16M Buy
173,685
+76,748
+79% +$1.41M 0.01% 935
2022
Q4
$1.86M Buy
96,937
+9,739
+11% +$206K 0.01% 935
2022
Q3
$1.64M Buy
87,198
+4,771
+6% +$98.1K ﹤0.01% 970
2022
Q2
$1.49M Sell
82,427
-23,132
-22% -$376K ﹤0.01% 1009
2022
Q1
$1.69M Buy
105,559
+3,073
+3% +$55.3K ﹤0.01% 1086
2021
Q4
$2.51M Buy
102,486
+353
+0.3% +$8.29K ﹤0.01% 990
2021
Q3
$2.38M Buy
102,133
+7,741
+8% +$187K ﹤0.01% 995
2021
Q2
$2.59M Buy
94,392
+94,125
+35,253% +$2.68M ﹤0.01% 1012
2021
Q1
$10K Sell
267
-106,183
-100% -$3.75M ﹤0.01% 1998
2020
Q4
$4M Buy
+106,450
New +$3.29M 0.01% 869

Other funds holding AHCO

Federated Hermes's AHCO Position: Q1 2025 in Review

Federated Hermes sold out of AdaptHealth (AHCO) in Q1 2025, closing a stake of 25,489 shares — an estimated $243K sold.

Federated Hermes first reported a position in AHCO in Q4 2020 and held it in 17 quarters. The position peaked at $5.14M in Q4 2023. 226 funds tracked by Wall St. Rank hold AHCO as of Q1 2025.

  • Federated Hermes reported no remaining AdaptHealth position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 25,489 AdaptHealth shares in Q1 2025, an estimated $243K.
  • Federated Hermes first reported a position in AdaptHealth in Q4 2020 and held it in 17 quarters.
  • Federated Hermes's AdaptHealth position peaked at $5.14M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.